Expectant management of mild preeclampsia versus superimposed preeclampsia up to 37 weeks

Amy M. Valent, Emily A. Defranco, Allessa Allison, Ahmed Salem, Lori Klarquist, Kyle Gonzales, Mounira Habli, Charles Adair, Casey Armistead, Yuping Wang, David Lewis, Baha Sibai

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective We sought to compare maternal and neonatal outcomes of expectantly managed pregnancies complicated by chronic hypertension with superimposed preeclampsia vs mild preeclampsia up to 37 weeks of gestation. Study Design This was a multicenter retrospective cohort study of all pregnancies complicated by chronic hypertension with superimposed preeclampsia or mild preeclampsia expectantly managed in the hospital from January 2008 through December 2011. The primary outcomes, adverse maternal and neonatal composite morbidities, were compared between these 2 groups. Frequency differences of maternal adverse outcomes were stratified by gestational age at delivery of <34 and 34-366/7 weeks of gestation. Results We found no significant differences in rates of neonatal composite morbidity or latency periods between women with superimposed preeclampsia and mild preeclampsia. Adverse neonatal outcomes were significantly higher at <34 compared to 34-366/7 weeks of gestation (97-98% vs 48-50%) in both cohorts. Maternal adverse composite outcome occurred more frequently in women with superimposed preeclampsia compared to mild preeclampsia (15% vs 5%; P =.003; relative risk, 3.0; 95% confidence interval, 1.45-6.29). Conclusion Women with superimposed preeclampsia have similar neonatal outcomes but more maternal complications than women with preeclampsia without severe features who are expectantly managed <37 weeks.

Original languageEnglish (US)
Pages (from-to)515.e1-515.e8
JournalAmerican Journal of Obstetrics and Gynecology
Volume212
Issue number4
DOIs
StatePublished - Apr 1 2015

Fingerprint

Pre-Eclampsia
Mothers
Pregnancy
Hypertension
Morbidity
Gestational Age
Cohort Studies
Retrospective Studies
Confidence Intervals

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology

Cite this

Valent, A. M., Defranco, E. A., Allison, A., Salem, A., Klarquist, L., Gonzales, K., ... Sibai, B. (2015). Expectant management of mild preeclampsia versus superimposed preeclampsia up to 37 weeks. American Journal of Obstetrics and Gynecology, 212(4), 515.e1-515.e8. https://doi.org/10.1016/j.ajog.2014.10.1090

Expectant management of mild preeclampsia versus superimposed preeclampsia up to 37 weeks. / Valent, Amy M.; Defranco, Emily A.; Allison, Allessa; Salem, Ahmed; Klarquist, Lori; Gonzales, Kyle; Habli, Mounira; Adair, Charles; Armistead, Casey; Wang, Yuping; Lewis, David; Sibai, Baha.

In: American Journal of Obstetrics and Gynecology, Vol. 212, No. 4, 01.04.2015, p. 515.e1-515.e8.

Research output: Contribution to journalArticle

Valent, AM, Defranco, EA, Allison, A, Salem, A, Klarquist, L, Gonzales, K, Habli, M, Adair, C, Armistead, C, Wang, Y, Lewis, D & Sibai, B 2015, 'Expectant management of mild preeclampsia versus superimposed preeclampsia up to 37 weeks', American Journal of Obstetrics and Gynecology, vol. 212, no. 4, pp. 515.e1-515.e8. https://doi.org/10.1016/j.ajog.2014.10.1090
Valent, Amy M. ; Defranco, Emily A. ; Allison, Allessa ; Salem, Ahmed ; Klarquist, Lori ; Gonzales, Kyle ; Habli, Mounira ; Adair, Charles ; Armistead, Casey ; Wang, Yuping ; Lewis, David ; Sibai, Baha. / Expectant management of mild preeclampsia versus superimposed preeclampsia up to 37 weeks. In: American Journal of Obstetrics and Gynecology. 2015 ; Vol. 212, No. 4. pp. 515.e1-515.e8.
@article{7925c81788ce40ff824239bc67fade5f,
title = "Expectant management of mild preeclampsia versus superimposed preeclampsia up to 37 weeks",
abstract = "Objective We sought to compare maternal and neonatal outcomes of expectantly managed pregnancies complicated by chronic hypertension with superimposed preeclampsia vs mild preeclampsia up to 37 weeks of gestation. Study Design This was a multicenter retrospective cohort study of all pregnancies complicated by chronic hypertension with superimposed preeclampsia or mild preeclampsia expectantly managed in the hospital from January 2008 through December 2011. The primary outcomes, adverse maternal and neonatal composite morbidities, were compared between these 2 groups. Frequency differences of maternal adverse outcomes were stratified by gestational age at delivery of <34 and 34-366/7 weeks of gestation. Results We found no significant differences in rates of neonatal composite morbidity or latency periods between women with superimposed preeclampsia and mild preeclampsia. Adverse neonatal outcomes were significantly higher at <34 compared to 34-366/7 weeks of gestation (97-98{\%} vs 48-50{\%}) in both cohorts. Maternal adverse composite outcome occurred more frequently in women with superimposed preeclampsia compared to mild preeclampsia (15{\%} vs 5{\%}; P =.003; relative risk, 3.0; 95{\%} confidence interval, 1.45-6.29). Conclusion Women with superimposed preeclampsia have similar neonatal outcomes but more maternal complications than women with preeclampsia without severe features who are expectantly managed <37 weeks.",
author = "Valent, {Amy M.} and Defranco, {Emily A.} and Allessa Allison and Ahmed Salem and Lori Klarquist and Kyle Gonzales and Mounira Habli and Charles Adair and Casey Armistead and Yuping Wang and David Lewis and Baha Sibai",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.ajog.2014.10.1090",
language = "English (US)",
volume = "212",
pages = "515.e1--515.e8",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Expectant management of mild preeclampsia versus superimposed preeclampsia up to 37 weeks

AU - Valent, Amy M.

AU - Defranco, Emily A.

AU - Allison, Allessa

AU - Salem, Ahmed

AU - Klarquist, Lori

AU - Gonzales, Kyle

AU - Habli, Mounira

AU - Adair, Charles

AU - Armistead, Casey

AU - Wang, Yuping

AU - Lewis, David

AU - Sibai, Baha

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Objective We sought to compare maternal and neonatal outcomes of expectantly managed pregnancies complicated by chronic hypertension with superimposed preeclampsia vs mild preeclampsia up to 37 weeks of gestation. Study Design This was a multicenter retrospective cohort study of all pregnancies complicated by chronic hypertension with superimposed preeclampsia or mild preeclampsia expectantly managed in the hospital from January 2008 through December 2011. The primary outcomes, adverse maternal and neonatal composite morbidities, were compared between these 2 groups. Frequency differences of maternal adverse outcomes were stratified by gestational age at delivery of <34 and 34-366/7 weeks of gestation. Results We found no significant differences in rates of neonatal composite morbidity or latency periods between women with superimposed preeclampsia and mild preeclampsia. Adverse neonatal outcomes were significantly higher at <34 compared to 34-366/7 weeks of gestation (97-98% vs 48-50%) in both cohorts. Maternal adverse composite outcome occurred more frequently in women with superimposed preeclampsia compared to mild preeclampsia (15% vs 5%; P =.003; relative risk, 3.0; 95% confidence interval, 1.45-6.29). Conclusion Women with superimposed preeclampsia have similar neonatal outcomes but more maternal complications than women with preeclampsia without severe features who are expectantly managed <37 weeks.

AB - Objective We sought to compare maternal and neonatal outcomes of expectantly managed pregnancies complicated by chronic hypertension with superimposed preeclampsia vs mild preeclampsia up to 37 weeks of gestation. Study Design This was a multicenter retrospective cohort study of all pregnancies complicated by chronic hypertension with superimposed preeclampsia or mild preeclampsia expectantly managed in the hospital from January 2008 through December 2011. The primary outcomes, adverse maternal and neonatal composite morbidities, were compared between these 2 groups. Frequency differences of maternal adverse outcomes were stratified by gestational age at delivery of <34 and 34-366/7 weeks of gestation. Results We found no significant differences in rates of neonatal composite morbidity or latency periods between women with superimposed preeclampsia and mild preeclampsia. Adverse neonatal outcomes were significantly higher at <34 compared to 34-366/7 weeks of gestation (97-98% vs 48-50%) in both cohorts. Maternal adverse composite outcome occurred more frequently in women with superimposed preeclampsia compared to mild preeclampsia (15% vs 5%; P =.003; relative risk, 3.0; 95% confidence interval, 1.45-6.29). Conclusion Women with superimposed preeclampsia have similar neonatal outcomes but more maternal complications than women with preeclampsia without severe features who are expectantly managed <37 weeks.

UR - http://www.scopus.com/inward/record.url?scp=84930403916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930403916&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2014.10.1090

DO - 10.1016/j.ajog.2014.10.1090

M3 - Article

VL - 212

SP - 515.e1-515.e8

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4

ER -